A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2018
At a glance
- Drugs Iodine-124-monoclonal antibody A33 (Primary) ; Monoclonal antibody A33; Monoclonal antibody A33
- Indications Colorectal cancer
- Focus Adverse reactions; Diagnostic use
- 17 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 17 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 01 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.